IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q1 2024 Holdings

Filed 2024-05-08 | 3 holdings | $180.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biohaven LTD(BHVN)COMG1110E107$160.6M2,936,50789.2%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$19.5M3,846,15410.8%
Viracta Therapeutics IncCOM92765F108$3.8K3,7000.0%